# Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB

Study · id `cardio:ct-nct07824492` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07824492](<https://clinicaltrials.gov/study/NCT07824492>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07824492

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 410 participants.

## Technical summary

Registry record NCT07824492. Randomized; no masking; primary purpose prevention. Start 2026-10-01 (anticipated); primary completion 2027-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 410 participants (planned count; ClinicalTrials.gov record NCT07824492, source copy `cardio:ctgov-nct07824492-2026-09-17`, retrieved 2026-10-26)
- Planned start: 2026-10-01 (anticipated) (ClinicalTrials.gov record NCT07824492, source copy `cardio:ctgov-nct07824492-2026-09-17`, retrieved 2026-10-26)
- Primary completion: 2027-10 (anticipated) (ClinicalTrials.gov record NCT07824492, source copy `cardio:ctgov-nct07824492-2026-09-17`, retrieved 2026-10-26)
- Completion: 2027-10 (anticipated) (ClinicalTrials.gov record NCT07824492, source copy `cardio:ctgov-nct07824492-2026-09-17`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07824492-2026-09-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB
- Acronym: TRAP-AF
- Condition: Atrial Fibrillation (AF)
- Condition: OPCABG
- Intervention (Device): Transcutaneous Auricular Vagus Nerve Stimulation
- Lead sponsor: Ruijin Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Ruijin Hospital (`cardio:org-ruijin-hospital`)

## Provenance

Content hash: d340a94cb2dc44665f9e4036c67be80647b276a8f95e513bfc3e79ae28d2e4fc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
